Evolent Health Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Evolent Health yıllık ortalama 35.7% oranında kazançlarını artırırken, Healthcare Services sektöründe kazançlar growing at 14% annual. Gelirler yılda ortalama 25.1% oranında büyüyor .

Anahtar bilgiler

35.7%

Kazanç büyüme oranı

42.6%

EPS büyüme oranı

Healthcare Services Sektör Büyümesi1.7%
Gelir büyüme oranı25.1%
Özkaynak getirisi-5.9%
Net Marj-4.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Nov 07
We Like These Underlying Return On Capital Trends At Evolent Health (NYSE:EVH)

Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Sep 19
Evolent Health (NYSE:EVH) Has A Pretty Healthy Balance Sheet

Evolent Health: Let The Bidding Begin

Aug 23

Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Jul 29
Potential Upside For Evolent Health, Inc. (NYSE:EVH) Not Without Risk

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Jul 01
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Recent Pullback, A Buying Opportunity Or Not? (Rating Downgrade)

May 22

These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

May 05
These 4 Measures Indicate That Evolent Health (NYSE:EVH) Is Using Debt Reasonably Well

Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Apr 08
Evolent Health, Inc. (NYSE:EVH) Doing What It Can To Lift Shares

Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Mar 12
Evolent Health (NYSE:EVH) Is Experiencing Growth In Returns On Capital

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Jan 17
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Dec 21
Many Still Looking Away From Evolent Health, Inc. (NYSE:EVH)

Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

Nov 30
Evolent Health (NYSE:EVH) Is Looking To Continue Growing Its Returns On Capital

A First Evaluation On Evolent Health

Oct 04

Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

Sep 29
Does Evolent Health (NYSE:EVH) Have A Healthy Balance Sheet?

There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

Sep 01
There's Been No Shortage Of Growth Recently For Evolent Health's (NYSE:EVH) Returns On Capital

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Aug 04
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 47% Undervalued

Evolent Health: Business Economics Still Appealing, Reiterate Buy

Jul 19

Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Jun 14
Cautious Investors Not Rewarding Evolent Health, Inc.'s (NYSE:EVH) Performance Completely

Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

May 30
Evolent Health (NYSE:EVH) Takes On Some Risk With Its Use Of Debt

An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

May 02
An Intrinsic Calculation For Evolent Health, Inc. (NYSE:EVH) Suggests It's 34% Undervalued

Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Apr 17
Evolent Health (NYSE:EVH) Shareholders Will Want The ROCE Trajectory To Continue

Evolent Health GAAP EPS of $0.11 beats by $0.13, revenue of $382.4M beats by $9.47M

Feb 22

Is Evolent Health (NYSE:EVH) A Risky Investment?

Feb 19
Is Evolent Health (NYSE:EVH) A Risky Investment?

Evolent Health: Strengthening Fundamentals, Investing At High Rates Of Return

Feb 15

Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Feb 01
Is Evolent Health, Inc. (NYSE:EVH) Potentially Undervalued?

Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Jan 14
Evolent Health (NYSE:EVH) Might Have The Makings Of A Multi-Bagger

Evolent spikes as Humana partnership expands

Jan 12

Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Dec 27
Is Evolent Health, Inc. (NYSE:EVH) Trading At A 49% Discount?

Evolent Health offered $23.5M class action securities settlement

Sep 19

Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Sep 18
Evolent Health's (NYSE:EVH) Returns On Capital Are Heading Higher

Evolent Health: Improving Financials, But There's More

Aug 31

Gelir ve Gider Dağılımı

Evolent Health nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

NYSE:EVH Gelir, gider ve kazançlar (USD Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 242,464-1042450
30 Jun 242,354-1062750
31 Mar 242,176-1412980
31 Dec 231,964-1423060
30 Sep 231,790-1123200
30 Jun 231,632-772980
31 Mar 231,483-402630
31 Dec 221,352-192440
30 Sep 221,218-42430
30 Jun 221,088-192290
31 Mar 22990-242150
31 Dec 21908-302080
30 Sep 21906-451990
30 Jun 21923-681990
31 Mar 21918-2611970
31 Dec 20925-3281980
30 Sep 20915-5151960
30 Jun 20895-5042070
31 Mar 20870-3342280
31 Dec 19687-3042080
30 Sep 19803-1212480
30 Jun 19733-1072470
31 Mar 19685-862410
31 Dec 18627-532310
30 Sep 18548-492200
30 Jun 18506-492060
31 Mar 18468-561990
31 Dec 17435-611950
30 Sep 17409-651910
30 Jun 17362-641800
31 Mar 17311-551630
31 Dec 16254-1601480
30 Sep 16212-1461310
30 Jun 16192-1471220
31 Mar 161462201030
31 Dec 1597330710
30 Sep 1551322380
30 Jun 1510329130
31 Mar 150-37-10
31 Dec 140-3100
30 Sep 1413-2970
31 Dec 13262160

Kaliteli Kazançlar: EVH şu anda kârlı değil.

Büyüyen Kar Marjı: EVH şu anda kârlı değil.


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: EVH kârlı değildir, ancak son 5 yılda zararlarını yılda 35.7% oranında azaltmıştır.

Büyüme Hızlandırma: EVH 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: EVH kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare Services sektörüyle ( 41.4% ) karşılaştırılması zorlaşıyor.


Özkaynak Getirisi

Yüksek ROE: EVH hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -5.89% ) sahiptir.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin